FDA Eyes OpenAI’s AI for Drug Evaluation
FDA Explores OpenAI’s AI for Drug Evaluations TThe U.S. Food and Drug Administration (FDA) is actively exploring the integration of artificial intelligence (AI) into its drug evaluation processes through discussions...